Annual SG&A:
$0.00-$249.75M(-100.00%)Summary
- As of today, RPRX annual SG&A is $0.00, with the most recent change of -$249.75 million (-100.00%) on December 31, 2024.
- During the last 3 years, RPRX annual SG&A has fallen by -$182.83 million (-100.00%).
- RPRX annual SG&A is now -100.00% below its all-time high of $249.75 million, reached on December 31, 2023.
Performance
RPRX SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$179.77M+$69.06M(+62.39%)Summary
- As of today, RPRX quarterly SG&A is $179.77 million, with the most recent change of +$69.06 million (+62.39%) on June 30, 2025.
- Over the past year, RPRX quarterly SG&A has increased by +$125.06 million (+228.60%).
- RPRX quarterly SG&A is now at all-time high.
Performance
RPRX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
$10.31B-$155.50M(-1.49%)Summary
- As of today, RPRX TTM SG&A is $10.31 billion, with the most recent change of -$155.50 million (-1.49%) on June 30, 2025.
- Over the past year, RPRX TTM SG&A has increased by +$10.08 billion (+4408.17%).
- RPRX TTM SG&A is now -1.49% below its all-time high of $10.47 billion.
Performance
RPRX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
RPRX Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | -100.0% | +228.6% | +4408.2% |
3Y3 Years | -100.0% | +246.8% | +5105.5% |
5Y5 Years | -100.0% | +320.0% | +6568.8% |
RPRX Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | -100.0% | at low | at high | +277.4% | -1.5% | +20.4% |
5Y | 5-Year | -100.0% | at low | at high | +316.6% | -1.5% | +42.8% |
All-Time | All-Time | -100.0% | at low | at high | +679.5% | -1.5% | +265.1% |
RPRX Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $179.77M(+62.4%) | $414.79M(+43.2%) |
Mar 2025 | - | $110.70M(+63.8%) | $289.72M(+22.4%) |
Dec 2024 | $0.00(-100.0%) | $67.59M(+19.2%) | $236.67M(+3.7%) |
Sep 2024 | - | $56.72M(+3.7%) | $228.26M(-0.2%) |
Jun 2024 | - | $54.71M(-5.1%) | $228.78M(+3.2%) |
Mar 2024 | - | $57.65M(-2.6%) | $221.71M(-11.2%) |
Dec 2023 | $249.75M(+9.9%) | $59.19M(+3.4%) | $249.75M(-5.3%) |
Sep 2023 | - | $57.23M(+20.2%) | $263.79M(+2.5%) |
Jun 2023 | - | $47.63M(-44.4%) | $257.25M(-1.6%) |
Mar 2023 | - | $85.69M(+17.0%) | $261.46M(+15.0%) |
Dec 2022 | $227.30M(+24.3%) | $73.23M(+44.5%) | $227.30M(+13.5%) |
Sep 2022 | - | $50.69M(-2.2%) | $200.24M(+1.1%) |
Jun 2022 | - | $51.84M(+0.6%) | $198.13M(+3.6%) |
Mar 2022 | - | $51.54M(+11.7%) | $191.21M(+4.6%) |
Dec 2021 | $182.83M | $46.16M(-5.0%) | $182.83M(-2.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | $48.59M(+8.2%) | $186.78M(-1.1%) |
Jun 2021 | - | $44.92M(+4.1%) | $188.93M(+1.1%) |
Mar 2021 | - | $43.16M(-13.9%) | $186.81M(+2.8%) |
Dec 2020 | $181.72M(+75.7%) | $50.12M(-1.2%) | $181.72M(+17.5%) |
Sep 2020 | - | $50.73M(+18.5%) | $154.66M(+19.4%) |
Jun 2020 | - | $42.80M(+12.4%) | $129.53M(+10.6%) |
Mar 2020 | - | $38.06M(+65.1%) | $117.08M(+13.2%) |
Dec 2019 | $103.44M(+67.1%) | $23.06M(-9.9%) | $103.44M(+28.7%) |
Sep 2019 | - | $25.60M(-15.6%) | $80.38M(+46.7%) |
Jun 2019 | - | $30.35M(+24.2%) | $54.77M(+124.2%) |
Mar 2019 | - | $24.43M | $24.43M |
Dec 2018 | $61.91M(-41.8%) | - | - |
Dec 2017 | $106.44M(+53.1%) | - | - |
Dec 2016 | $69.51M(-42.7%) | - | - |
Dec 2015 | $121.42M | - | - |
FAQ
- What is Royalty Pharma plc annual SG&A?
- What is the all-time high annual SG&A for Royalty Pharma plc?
- What is Royalty Pharma plc annual SG&A year-on-year change?
- What is Royalty Pharma plc quarterly SG&A?
- What is the all-time high quarterly SG&A for Royalty Pharma plc?
- What is Royalty Pharma plc quarterly SG&A year-on-year change?
- What is Royalty Pharma plc TTM SG&A?
- What is the all-time high TTM SG&A for Royalty Pharma plc?
- What is Royalty Pharma plc TTM SG&A year-on-year change?
What is Royalty Pharma plc annual SG&A?
The current annual SG&A of RPRX is $0.00
What is the all-time high annual SG&A for Royalty Pharma plc?
Royalty Pharma plc all-time high annual SG&A is $249.75M
What is Royalty Pharma plc annual SG&A year-on-year change?
Over the past year, RPRX annual SG&A has changed by -$249.75M (-100.00%)
What is Royalty Pharma plc quarterly SG&A?
The current quarterly SG&A of RPRX is $179.77M
What is the all-time high quarterly SG&A for Royalty Pharma plc?
Royalty Pharma plc all-time high quarterly SG&A is $179.77M
What is Royalty Pharma plc quarterly SG&A year-on-year change?
Over the past year, RPRX quarterly SG&A has changed by +$125.06M (+228.60%)
What is Royalty Pharma plc TTM SG&A?
The current TTM SG&A of RPRX is $10.31B
What is the all-time high TTM SG&A for Royalty Pharma plc?
Royalty Pharma plc all-time high TTM SG&A is $10.47B
What is Royalty Pharma plc TTM SG&A year-on-year change?
Over the past year, RPRX TTM SG&A has changed by +$10.08B (+4408.17%)